China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)

SHE:300294 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,388	15,269	16,983	18,435	19,338	14,286
Market Cap Growth	-6.41%	-10.10%	-7.88%	-4.67%	35.36%	7.40%
Enterprise Value	10,051	10,035	11,919	13,978	17,731	14,221
Last Close Price	26.55	30.28	33.20	35.85	37.41	32.66
PE Ratio	34.56	38.46	71.52	42.66	56.13	54.93
Forward PE	23.88	26.00	29.00	30.95	32.40	32.75
PS Ratio	7.35	8.80	6.40	6.68	7.30	5.69
PB Ratio	1.76	2.04	2.32	2.53	2.79	3.41
P/TBV Ratio	2.18	2.55	2.43	2.97	3.23	4.40
P/FCF Ratio	-	149.71	30.64	40.25	15.14	24.80
P/OCF Ratio	100.07	50.93	26.47	30.91	14.37	19.88
EV/Sales Ratio	5.52	5.78	4.49	5.07	6.69	5.66
EV/EBITDA Ratio	20.40	19.30	19.09	23.28	34.72	34.56
EV/EBIT Ratio	25.69	23.77	22.52	27.56	42.78	43.07
EV/FCF Ratio	-61.93	98.40	21.51	30.52	13.88	24.69
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.01	0.08
Debt / EBITDA Ratio	0.02	0.02	0.04	0.06	0.07	0.80
Debt / FCF Ratio	-	0.12	0.04	0.08	0.03	0.57
Asset Turnover	0.22	0.21	0.33	0.35	0.42	0.48
Inventory Turnover	0.93	0.79	2.06	1.87	1.74	1.61
Quick Ratio	5.81	5.40	12.85	7.65	7.83	1.71
Current Ratio	7.25	6.74	14.08	8.61	8.95	3.36
Return on Equity (ROE)	5.09%	5.36%	3.40%	6.27%	6.45%	6.73%
Return on Assets (ROA)	2.97%	3.25%	4.17%	4.05%	4.05%	3.96%
Return on Capital (ROIC)	3.23%	3.55%	4.51%	4.44%	4.51%	4.52%
Return on Capital Employed (ROCE)	5.00%	5.50%	7.20%	6.90%	5.90%	7.70%
Earnings Yield	2.87%	2.60%	1.40%	2.34%	1.78%	1.82%
FCF Yield	-1.21%	0.67%	3.26%	2.48%	6.60%	4.03%
Dividend Yield	1.21%	1.06%	0.90%	0.56%	0.40%	0.20%
Payout Ratio	60.45%	58.54%	42.47%	19.25%	13.36%	34.15%
Buyback Yield / Dilution	1.25%	0.54%	-0.53%	-15.24%	-2.30%	-0.04%
Total Shareholder Return	2.45%	1.60%	0.37%	-14.68%	-1.89%	0.16%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.